159 related articles for article (PubMed ID: 6741844)
1. Long-term antiarrhythmic therapy with flecainide.
Meinertz T; Zehender MK; Geibel A; Treese N; Hofmann T; Kasper W; Pop T
Am J Cardiol; 1984 Jul; 54(1):91-6. PubMed ID: 6741844
[TBL] [Abstract][Full Text] [Related]
2. Oral flecainide for suppression of ventricular arrhythmias.
Vanhaleweyk G; Balakumaran K; Lubsen J; Roelandt J; Hugenholtz PG
Cardiology; 1984; 71(1):30-9. PubMed ID: 6722846
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
Kjekshus J; Bathen J; Orning OM; Storstein L
Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
[TBL] [Abstract][Full Text] [Related]
4. Flecainide: a new agent for the treatment of ventricular arrhythmias.
Grubb BP; Tilley-Gray B
Am J Med Sci; 1986 Sep; 292(3):160-3. PubMed ID: 3529958
[TBL] [Abstract][Full Text] [Related]
5. Flecainide versus quinidine: results of a multicenter trial.
Hodges M; Salerno DM; Granrud G
Am J Cardiol; 1984 Feb; 53(5):66B-71B. PubMed ID: 6364770
[TBL] [Abstract][Full Text] [Related]
6. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerance of intravenous flecainide in patients with chronic high frequency ventricular arrhythmias.
Stroobandt R; Andries E; van Mieghem W; Kesteloot H
Eur Heart J; 1984 Nov; 5(11):876-82. PubMed ID: 6397356
[TBL] [Abstract][Full Text] [Related]
8. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J
Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
[TBL] [Abstract][Full Text] [Related]
10. Use of flecainide acetate in the treatment of premature ventricular contractions.
Abitbol H; Califano JE; Abate C; Beilis P; Castellanos H
Am Heart J; 1983 Feb; 105(2):227-30. PubMed ID: 6823803
[TBL] [Abstract][Full Text] [Related]
11. Flecainide dose-response relations in stable ventricular arrhythmias.
Woosley RL; Siddoway LA; Duff HJ; Roden DM
Am J Cardiol; 1984 Feb; 53(5):59B-65B. PubMed ID: 6695819
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
[TBL] [Abstract][Full Text] [Related]
13. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.
Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL
Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461
[No Abstract] [Full Text] [Related]
14. Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.
Circulation; 1983 May; 67(5):1117-23. PubMed ID: 6339110
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effects of flecainide.
Somani P
Clin Pharmacol Ther; 1980 Apr; 27(4):464-70. PubMed ID: 7357804
[TBL] [Abstract][Full Text] [Related]
16. Suppression of complex ventricular arrhythmias by oral flecainide.
Duran D; Platia EV; Griffith LS; Adhar G; Reid PR
Clin Pharmacol Ther; 1982 Nov; 32(5):554-61. PubMed ID: 7127996
[TBL] [Abstract][Full Text] [Related]
17. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG
Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395
[TBL] [Abstract][Full Text] [Related]
18. A proposal for the clinical use of flecainide.
Anderson JL; Stewart JR; Crevey BJ
Am J Cardiol; 1984 Feb; 53(5):112B-119B. PubMed ID: 6364767
[TBL] [Abstract][Full Text] [Related]
19. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
[TBL] [Abstract][Full Text] [Related]
20. [Flecainide: a new antiarrhythmic agent].
Leclercq JF; Coumel P
Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
